Literature DB >> 34776497

Remote Recurrence from Ovarian Cancer Mimicking Lung Cancer.

Sho Yamada1, Akimasa Sekine1, Takashi Ogura1.   

Abstract

Entities:  

Keywords:  metastatic lung cancer; metastatic relapse; ovarian cancer

Mesh:

Year:  2021        PMID: 34776497      PMCID: PMC9259828          DOI: 10.2169/internalmedicine.8751-21

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.282


× No keyword cloud information.
A 50-year-old woman who had undergone primary resection for ovarian cancer pathologically staged as 1C 13 years earlier developed a dry cough. She had completed follow-up without recurrence at 46 years old. Chest computed tomography revealed mass lesions in the right lung and pleural effusion (Picture A, B), and one month of treatment with antibiotic was unsuccessful. Thus, she was referred to our hospital under suspicion of lung cancer. On admission, she required supplementary oxygen. Laboratory tests showed elevated concentrations of cancer antigen 125. Lymphangitic carcinomatosis, rapidly growing masses, and an increase in pleural effusion were noted radiographically (Picture C, D), whereas extrathoracic lesions were not detected. A pathologic analysis of a transbronchial lung biopsy specimen and pleural effusion revealed adenocarcinoma. Positive immunoreactivity for paired box gene 8 confirmed recurrent ovarian cancer. She was transferred to the gynecology department but unfortunately died before receiving chemotherapy. Recurrent ovarian cancer can have remote manifestations confined to the thorax (1), even after long-term follow-up.
Picture.
The authors state that they have no Conflict of Interest (COI).
  1 in total

Review 1.  Imaging features of thoracic metastases from gynecologic neoplasms.

Authors:  Santiago Martínez-Jiménez; Melissa L Rosado-de-Christenson; Christopher M Walker; Jeffery R Kunin; Sonia L Betancourt; Brenda L Shoup; Paul P Pettavel
Journal:  Radiographics       Date:  2014-10       Impact factor: 5.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.